SANUWAVE Health, Inc.: 10-Q filed 2017-11-14
What SANUWAVE Health, Inc. reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 38 published measures, 103 facts as tagged in accession 0001654954-17-010649.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-11-14
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001654954-17-010649 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANUWAVE Health, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 565,310 | USD | |
| At 2016-12-31 | 1,004,870 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 9,588,573 | USD | |
| At 2016-12-31 | 7,916,470 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -9,023,263 | USD | |
| At 2016-12-31 | -6,911,600 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 40,226 | USD | |
| At 2016-12-31 | 133,571 | USD | |
| At 2016-09-30 | 504,404 | USD | |
| At 2015-12-31 | 152,930 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -851,325 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,760,794 | USD | 273 |
| 2016-01-01 to 2016-12-31 | -6,439,040 | USD | 366 |
| 2016-07-01 to 2016-09-30 | -1,139,810 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -3,986,509 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -944,831 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -2,708,973 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 7,878 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 161,585 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 422,199 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 255,652 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 728,382 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 844,683 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 3,072,305 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -6,878 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -102,194,242 | USD | |
| At 2016-12-31 | -99,433,448 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 59,395 | USD | |
| At 2016-12-31 | 76,938 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 482,295 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 116,550 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -647,778 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,577,842 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -833,605 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -2,541,245 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 491,993 | USD | |
| At 2016-12-31 | 914,146 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 160,978 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 496,997 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 259,302 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 623,066 | USD | 274 |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,435,431 | USD | |
| At 2016-12-31 | 712,964 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 172,119 | USD | |
| At 2016-12-31 | 460,799 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 747,679 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 2,858,518 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 990,579 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,019,780 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 176,109 | USD | |
| At 2016-12-31 | 231,953 | USD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 61,684 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 141,523 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 98,678 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 249,847 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 266,837 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 965,084 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 266,473 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,052,595 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 139,099,843 | shares | |
| At 2016-12-31 | 137,219,968 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 93,077,145 | USD | |
| At 2016-12-31 | 92,436,697 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -45,266 | USD | |
| At 2016-12-31 | -52,069 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 532,165 | USD | |
| At 2016-12-31 | 532,165 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 472,770 | USD | |
| At 2016-12-31 | 455,227 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 13,922 | USD | |
| At 2016-12-31 | 13,786 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 459,735 | USD | |
| At 2016-12-31 | 375,088 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -830,755 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,753,991 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -1,142,078 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -3,991,489 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 475,377 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,875,891 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 645,863 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,734,891 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 5,465 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 17,543 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 1,554 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,227 | USD | 274 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 0 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 76,689 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 230,067 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -203,547 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -182,952 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -306,205 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -1,445,264 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 630,549 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -200,850 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 82,219 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -55,844 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -17,922 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 722,467 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -133,173 | USD | 274 |
Inspect the source
- Entity
- SANUWAVE Health, Inc. / CIK 0001417663
- Captured
- 2026-09-20T08:02:35.518Z
- SEC response SHA-256
51a2d5afc6b3c84f5ebe71aa20944ba7646a9b22810a9cc023a45d564e5104f2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001417663.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))